DiggLead source
Anthropic says it has started its own Claude-assisted drug discovery while partnering with six medicine makers, and it says early work has improved lab design, paperwork review and clinical planning.Read original on X
StoryFirst seen
Anthropic starts its own drug discovery work alongside six partners
The move puts the AI lab in direct territory of the drug developers that buy its models.
Archived Updated
Everything it touches
2 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
Shared connections
Related stories
Claude for Legal adds ready-made artifacts for contract review
The gallery lets teams share the same legal workflows across the business, starting from a built-in example.
Anthropic starts its own drug discovery work alongside six partners
The move puts the AI lab in direct territory of the drug developers that buy its models.
Anthropic's IPO filing shows $11.6 billion in second-quarter revenue
Revenue from existing customers grew ninefold in a year, adding pressure on rival OpenAI as both compete on price and capability.
Banks to finance $63 billion of Broadcom chips for Anthropic
The leasing vehicle shows how large AI compute purchases are being financed through Wall Street rather than the AI lab's own balance sheet.